Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease. (Q48659706)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 July 2015

Language	Label	Description	Also known as
English	Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease.	scientific article published on 21 July 2015

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

steatohepatitis

0 references

ventricular dysfunction

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

author name string

Murat Sunbul

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Tarik Kivrak

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Erdal Durmus

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Hakan Akin

4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Yucel Aydin

5

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Rabia Ergelen

6

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Yusuf Yilmaz

7

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Mehmet Agirbasli

8

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

publication date

21 July 2015

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Cardiovascular Therapeutics

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

33

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

5

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

294-299

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

Epidemiology and natural history of patients with NAFLD.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD?

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Evaluation of cardiac function by two-dimensional speckle tracking echocardiography in ulcerative colitis patients.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Effect of vitamin D deficiency and supplementation on myocardial deformation parameters and epicardial fat thickness in patients free of cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension. Speckle-tracking echocardiographic study.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Right ventricular function in hypertrophic cardiomyopathy: A speckle tracking echocardiography study

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Emerging clinical role of strain imaging in echocardiography.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Two dimensional speckle tracking echocardiography: clinical applications

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Sample size determination for logistic regression revisited

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Sample size and optimal design for logistic regression with binary interaction

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Timing and magnitude of regional right ventricular function: a speckle tracking-derived strain study of normal subjects and patients with right ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study).

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Right ventricular longitudinal deformation parameters and exercise capacity : prognosis of patients with chronic thromboembolic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12145

21 January 2018

Identifiers

10.1111/1755-5922.12145

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26202098

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48659706&oldid=1539205886"